Get the Stockscreener App
3.97
4.20%
0.16
Pre-market:
4.01
0.04
+1.01%
Agenus Inc stock is traded at $3.97, with a volume of 468.98K.
It is up +4.20% in the last 24 hours and up +3.12% over the past month.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
See More
Previous Close:
$3.81
Open:
$3.99
24h Volume:
468.98K
Relative Volume:
1.00
Market Cap:
$126.50M
Revenue:
$160.43M
Net Income/Loss:
$-227.64M
P/E Ratio:
-0.0577
EPS:
-68.77
Net Cash Flow:
$-170.79M
1W Performance:
-4.11%
1M Performance:
+3.12%
6M Performance:
+37.37%
1Y Performance:
-5.48%
1-Day Range:
$3.90
$4.105
1-Week Range:
$3.77
$4.22
52-Week Range:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Name
Agenus Inc
Sector
Industry
Phone
781-674-4410
Address
3 FORBES ROAD, LEXINGTON, MA
Compare AGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
3.97 | 121.40M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-04-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-19-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-18-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-06-23 | Initiated | Robert W. Baird | Outperform |
| Feb-28-23 | Resumed | H.C. Wainwright | Buy |
| Sep-28-22 | Initiated | SMBC Nikko | Outperform |
| Dec-16-21 | Initiated | H.C. Wainwright | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Apr-22-19 | Initiated | B. Riley FBR | Buy |
| Oct-28-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-27-16 | Reiterated | Maxim Group | Buy |
| Mar-11-16 | Upgrade | Maxim Group | Hold → Buy |
| Dec-16-15 | Initiated | Jefferies | Buy |
| Oct-27-15 | Downgrade | Maxim Group | Buy → Hold |
| Jul-27-15 | Reiterated | MLV & Co | Buy |
| Jun-11-15 | Initiated | Oppenheimer | Outperform |
| Jan-12-15 | Reiterated | Maxim Group | Buy |
| Jan-09-15 | Reiterated | MLV & Co | Buy |
| Jan-09-15 | Reiterated | Maxim Group | Buy |
| Dec-19-14 | Reiterated | Maxim Group | Buy |
| May-08-14 | Reiterated | Maxim Group | Buy |
| Mar-14-14 | Reiterated | MLV & Co | Buy |
| Oct-08-13 | Reiterated | Maxim Group | Buy |
| Jan-05-12 | Initiated | William Blair | Outperform |
| Dec-01-11 | Initiated | Global Hunter Securities | Buy |
View All
Agenus Inc Stock (AGEN) Latest News
What is the fair value of Agenus Inc. stock nowPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Will Agenus Inc. (AJ8) stock top growth indexes2025 Year in Review & Verified Stock Trade Ideas - newser.com
Is Agenus Inc. stock poised for growth2025 Dividend Review & Stepwise Trade Execution Plans - newser.com
Should you wait for a breakout in Agenus Inc.Portfolio Performance Report & Real-Time Stock Movement Alerts - newser.com
Forecasting Agenus Inc. price range with options dataWeekly Trade Report & Long-Term Safe Return Strategies - newser.com
Is Agenus Inc. (AJ8) stock worth buying before Fed actionEarnings Growth Report & Precise Swing Trade Entry Alerts - newser.com
Using R and stats models for Agenus Inc. forecasting2025 Top Decliners & AI Optimized Trading Strategy Guides - newser.com
Can Agenus Inc. stock resist sector downturnsQuarterly Profit Review & Expert Approved Momentum Ideas - newser.com
How Agenus Inc. (AJ8) stock reacts to fiscal policiesJuly 2025 Chart Watch & Safe Entry Point Identification - newser.com
Is Agenus Inc. stock supported by innovation pipelineJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Will Agenus Inc. (AJ8) stock sustain bullish trend into 2025July 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
How Agenus Inc. (AJ8) stock responds to bond marketWeekly Trading Summary & Risk Managed Investment Strategies - newser.com
Will Agenus Inc. stock outperform value stocksMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Is Agenus Inc. a candidate for recovery playQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Can swing trading help recover from Agenus Inc. lossesQuarterly Market Review & Momentum Based Trading Signals - newser.com
What data driven models say about Agenus Inc.’s future2025 Historical Comparison & AI Driven Stock Movement Reports - newser.com
How Agenus Inc. stock performs in high volatility marketsJuly 2025 Patterns & Intraday High Probability Setup Alerts - newser.com
Earnings visualization tools for Agenus Inc.July 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Candlestick signals on Agenus Inc. stock todayQuarterly Market Review & Verified Technical Trade Signals - newser.com
Is Agenus Inc. (AJ8) stock trading at attractive multiplesFed Meeting & Technical Confirmation Alerts - newser.com
Agenus Inc. (AGEN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Agenus Inc. (AGEN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Agenus: Immunotherapy shift could reshape cancer treatment - Traders Union
Turning Hope Into Healing: Gateway for Cancer Research and the BOT/BAL Breakthrough in Colorectal Cancer - Oncodaily
What drives Agenus Inc AJ8 stock priceSupport Level Holds & Access Powerful Market Insights - earlytimes.in
Commentary: FDA must keep up with science on cancer - Grand Forks Herald
Agenus Inc Stock (AGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):